-
Mashup Score: 2
Anthony A. Bavry, MD, MPH, FACC
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
According to data from 60 nationally representative US emergency departments, visits attributed to medication harms in 2017-2019 were frequent, with variation in products and intent of use by age.
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
Add this paper to the rapidly growing list justifying #cvCoag stewardship programs - we can't just "ignore" this problem - it's the #1 cause of ADEs in US Emergency Departments!!! (https://t.co/wrsVTFs2xq from @CDCgov)
-
-
Mashup Score: 2Anticoagulant drug-drug interactions: Highlighting the need for antithrombotic stewardship and shared decision making - PubMed - 2 year(s) ago
Anticoagulant drug-drug interactions: Highlighting the need for antithrombotic stewardship and shared decision making
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
Learn more about why #cvCoag stewardship is so important from these editorials in @RPTHjournal: https://t.co/HbY988rbue & https://t.co/el91Ai6Boi. @aburnett_PharmD
-
-
Mashup Score: 4
Dharam J. Kumbhani, MD, SM, FACC; Amit Saha, MD
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The ELAN trial demonstrated similar safety and efficacy with early versus later DOAC initiation in patients with nonvalvular #AFib and acute ischemic #stroke. Find out more: https://t.co/eyg52b8AB1 #cvCoag
-
-
Mashup Score: 6
The findings of this cohort study suggest that patients with AF who are not receiving anticoagulation are more willing to consider anticoagulation than their physicians. These data emphasize the need to revisit any prior decision against anticoagulation in a shared decision-making manner.
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
This fascinating study of #AFib undertreatment suggests 2 key #ImpSci questions: 1) Why do pts value #cvCoag more than clinicians for AFib? 2) Why do front-line clinicians feel reluctant to start anticoag when external adjudicators feel it's appropriate? https://t.co/En6CERp6Qh
-
-
Mashup Score: 3
Centro Latinoamericano para Promoción de la Salud Cardiovascular : Una colaboración estratégica que aportará herramientas clínicas relevantes para los médicos de toda Latinoamérica a fin de optimizar la asistencia a la salud cardiológica.
Source: espanol.medscape.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ACC & Medscape Latin America have created the Center for Excellence for CV Health Promotion. This 🤝 brings trusted scientific information & resources, on #heartfailure, #AFib, #cvCoag & more, relevant to physicians throughout #LatinAmerica. Learn more: https://t.co/30iEP2dAgT https://t.co/O027SQk7yy
-
-
Mashup Score: 1Full-Dose Anticoagulation Again Favored for COVID Admissions - 2 year(s) ago
Despite failures, FREEDOM trial supports mortality advantage in general ward use
Source: www.medpagetoday.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Full-dose #cvCoag did not improve overall outcomes for non-ICU admissions for #COVID19, according to the FREEDOM trial reported at #ACC23/#WCCardio. @cphend reports on the findings in @medpagetoday: https://t.co/1ZlhrHQ8O5
-
-
Mashup Score: 2ACC Online Courses - American College of Cardiology - 2 year(s) ago
Find information and links to ACC Online Courses on this page.
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Interested in learning more on Special Topics learning pathway? ACC Online Courses have got you covered w/ free #ACCEd 👇 ✅ Genetic Testing in #Cardiology ✅ Clinical Spotlight Series on topics including #cvCoag, #AFib & more. 🔗 https://t.co/zJJzKjgILQ #ACC23 #WCCardio https://t.co/0ZhgVuRBtj
-
-
Mashup Score: 4
Therapeutic-dose anticoagulation did not significantly reduce the combined risk of death from any cause, need of intensive care unit (ICU) treatment, a confirmed blood clot or stroke in noncritically ill patients hospitalized for COVID-19, but did lower rates of intubation and death, according to results from the FREEDOM COVID trial presented at ACC.23/WCC and simultaneously published in…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Based on the results from FREEDOM COVID trial presented at #ACC23/#WCCardio, therapeutic-dose anticoagulation shows no significant composite risk reduction for noncritical, hospitalized #COVID19 patients. More: https://t.co/PBtSGvcG8D #cvCoag #CardioTwitter https://t.co/TFqwHAYqQt
-
-
Mashup Score: 2Adherence to thrombophilia testing guidelines and its influence on anticoagulation therapy: A single-center cross-sectional study - 2 year(s) ago
The collected evidence on thrombophilia guidelines is scarce and data about their impact on clinical decisions are unknown. We aimed to investigate th…
Source: www.sciencedirect.comCategories: Hematologists1, Latest HeadlinesTweet-
😬Adherence to thrombophilia testing guidelines 🇨🇭 Of 3686 included patients, mostly referred for VTE (65 %) or arterial thrombosis (6 %) ❌96 % underwent thrombophilia testing‼️ ❌Indication was according to guidelines in 33 % @ThrombosisRese1 #CVcoag https://t.co/szKyN3eSmo
-
The ELAN trial showed possible benefit of early anticoagulation compared with delayed anticoagulation after acute ischemic stroke and #AFib. Read more about the clinical trial here: https://t.co/ICsoALPIN0 #cvCoag